In November 2024, Seno Medical secured an Innovative Technology contract from Vizient for its Imagio breast imaging system, a breakthrough device designed to enhance the diagnostic process for breast cancer. The system combines opto-acoustic and ultrasound imaging to provide real-time, non-invasive insights into breast masses, aiming to reduce the need for invasive biopsies. A contract from Vizient for the Imagio breast imaging system represents a significant advancement and will help transform breast cancer diagnostics, says GlobalData, a leading data and analytics company.

GlobalData forecasts the global breast imaging market to reach $4.7 billion by 2025, fueled by technological advancements and growing awareness of breast cancer screening. The broader diagnostic imaging market is projected to grow to $38.9 billion by 2027 at a 5.1% CAGR during 2024-27, driven by the demand for advanced imaging technologies like full-field digital mammography.

Graysen Vigneux, Medical Analyst at GlobalData, comments: “Seno Medical’s Imagio breast imaging system introduces a transformative diagnostic solution that bridges the gap between traditional imaging methods and patient-centered care. By reducing the reliance on invasive biopsies, this technology significantly improves both diagnostic accuracy and patient outcomes.”

The Imagio system’s hybrid imaging technology combines functional and anatomical imaging to provide real-time insights into tissue composition and blood vessel structures, delivering a comprehensive view of breast masses. This non-invasive approach enhances diagnostic accuracy while reducing the burden of unnecessary procedures, aligning with the growing focus on patient-centered care.

Vigneux concludes: “Breast cancer diagnostics has long been an area in need of innovation. The Imagio system is designed to not only redefine diagnostic workflows but also enhance the overall patient journey by delivering accurate, timely, and less intrusive care. Seno Medical’s partnership with Vizient is a testament to the system’s potential to become a new standard in breast imaging technology, driving better outcomes for patients and healthcare providers alike.”